ArticleFrontiers in immunology2022

Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.

Ron Milo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.